| Literature DB >> 18937030 |
Lalitha R Belur1, William F Kaemmerer, R Scott McIvor, Walter C Low.
Abstract
The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18937030 PMCID: PMC4393077 DOI: 10.1007/s00705-008-0222-7
Source DB: PubMed Journal: Arch Virol ISSN: 0304-8608 Impact factor: 2.574